Synthesis of Peptides Related to Gramicidin S. II. 1 The Decapeptide

Mar 5, 2017 - BY BERNARD F. ERLANGER, WILLIAM V. CURRAN AND NICHOLAS KOKOWSKY. RECEIVED SEPTEMBER 30, 1957. The synthesis of a ...
0 downloads 0 Views 518KB Size
B. F. ERLANGER, W. V. CURRAN AND N. KOKOWSKY

1128 [CONTRIBUTION FROM THE

vOi. so

DEPARTMENT OF MICROBIOLOGY, COLLEGE O F PHYSrCIANS AND SURGEONS, cOi,IJ.MBIA UNIVERSITY 1

Synthesis of Peptides Related to Gramicidin S. 11.' The Decapeptide Containing D-Tyrosine Residues in Place of D-Phenylalanine2 BY BERNARD F. ERLANGER, WILLIAMV. CURRAN AND NICHOLAS KOKOWSKY RECEIVED SEPTEMBER 30, 1957 The synthesis of a decapeptide analog of gramicidin S is described. taining two n-tyrosine residues instead of two D-phenylananines.

It differs from the latter in being acyclic aiid con-

NH, (L-L-L-D-L), could not be prepared in a sufliciently pure state. The condensation of the tetra- and hexapeptide H .Val-Om-Leu-Tyr-Pro-Val-Orn-Leu-Tyr-Pro .OH 3HCI derivatives yielded a product which could not be (L-L-L-D-L)z(I)~ crystallized despite many attempts using a number was synthesized. This decapeptide differs from of solvent systems. This is not an uncommon exgramicidin S in two respects: (a) it is acyclic and perience when high molecular weight polypeptides (b) it contains D-tyrosine residues in place of the are being synthesized. However, since we had D-phenylanaine residues of gramicidin S. The been fortunate enough to have obtained crystalline, crystalline decapeptide described in paper I of this sharp melting decapeptide derivatives as intermeseries,' H-Val-Om-Leu-Phe-Pro-Val-Orn-Leu-Phe- diates for the synthesis of 11,' it was decided to inPro.OH.3HCI (L-L-L-D-L)~ (11) differs from grami- vestigate the possibility that the product was imcidin S only with respect to its acyclic nature. pure. Consequently, an attempt was made to These interrelationships are illustrated in Fig. 1. purify the amorphous preparation by means of adi 1 sorption chromatography on alumina and Florisil. Val-Om-Leu-Phe-Pro-Val-Om-Leu-Plie-Pro A product was obtained which analyzed correctly (L-L-L-D-L)~ Gramicidin S and could be crystallized. Since this purified maH .Val-Om-Leu-Tyr-Pro-Val-Om-Leu-Tyr-Pro .OH terial comprised only about 30% by weight of the (L-L-L-D-L)~ I total crude product, it is quite apparent that H .Val-Om-Leu-Phe-Pro-Val-Orn-Leu-Phe-Pro.OH utilization of the latter, without further purifica(L-L-L-D-L)~ 11 tion, for subsequent synthetic steps would not have been a feasible procedure. It is suggested that Fig. 1.-Synthetic decapeptides. the use of adsorption chromatography for t-he The methods used to synthesize decapeptide I purification of peptide intermediates could have were chosen with the purpose of avoiding the for- aided in the crystallization of a number of those mation of mixtures of diastereoisomers. Thus the derivatives previously obtained (by this and other azide route was employed when acylated dipep- laboratories) as amorphous solids. Our experitides (or acylated derivatives of higher peptides) ence, in addition, emphasizes the risks inherent in served as intermediate^.^ An outline of the meth- the utilization of non-crystallizable intermediates ods and techniques used appears in Fig. 2. in peptide synthesis. The over-all synthetic scheme differs from the Adsorption chromatography also was used to one used to synthesize decapeptide I1 with respect purify the saponified decapeptide derivative. The to the polypeptide derivatives which were linked free decapeptide was prepared from the latter by to produce the desired decapeptide. Decapeptide removal of the carbobenzyloxy and p-toluenesulTI was formed from two pentapeptide derivatives : fonyl groups with sodium and liquid ammonia.6 Z~Val-p-Tos~Orn-Leu-Phe-Pro.NH~NH, (L-L-L-D-L) It was separated from inorganic salts by isolation and H.Val-p-Tos~Orn-Leu-Phe-Pro.OMe (L-L-L-D- of the picrate derivative, and subsequent decompoL ) . On the other hand, decapeptide I was the sition of the latter by acid. Characterization was product of the reaction between a tetrapeptide by dinitrophenylation and hydrolysis studies. derivative and a hexapeptide derivative : Z.Val-pAssay for antibacterial activity will be carried Tos.0rn-Leu-Tyr.NH.NH2(L-L-L-D) and H.Pro-L7al- out when the synthesis of several other decapepp-Tos.Orn-Leu-Tyr-Pro.O?IIe (L-L-L-L-D-L) . This tides is completed. modification was necessary because the pentapepExperimental' tide hydrazide, 2.Val-p-Tos.Orn-Leu-Tyr-Pro.NII As part of a study of the antibacterial activity of synthetic decapeptides related to gramicidin S,

1. H.Tyr.OBz.HC1 (D).-This cornp(iund was prepared (1) For paper I, see: B. F. Erlanger, 13. Sachs and E. Brand, THIS b y the method of Erlanger and The yield from 14 g. 1 6 , 1806 (1954). (0.077 mole) of D-tyrosine was 14 g. (GO%,), m.p. 200°, (2) T h i s work is supported b y t h e Office of Naval Research under [a]% +20.8 (0.57, in 0.1 N hydrochloric acid, c:rlcd. as A preliminary account appears in the Abcontract N-onr-266(44). free base). Reference 8 reports m.p. 205", [a]% -23.3 stracts of the 131st American Chemical Society meeting, A l i s i i n i , ]:la,, for the L-isomer. April, 1957, p. 18-C. 2. Z.Leu-Tyr.OEt (L-D).--IS.~ fi. (0.071 rriole) of %.TJeu. ( 3 ) Cf.B. F. Erlangcr and L. Goode, X n l i r t e , 174, 840 ( 1 9 5 4 ) . OH ( L ) was ~ dissnlvc(l i n 100 1111. of tctr;ihytlrcifura~~ roritniii( 4 ) For explanation of the abbreviations. see €3. F. Erlanger ant1 I C . nranrl. THISJ O U R N A L , 73, 3508 (1951), and paper I of thi-. series (d. 1). Briefly: 2, carbobenzyloxy. CGH~CH:OCO; f i - ' r t ~fi(6) 1'. d i i l ' , ~ n v : t i i < l i i t i c l 0 . 1;. i{elii-cns, .I. Tqiol. ( I z r i i i . , 117, 27 toluenesulfonyl. CIH~SOI; Leu, N I I . ( C H C I H ~ ) C O ;V a l , E I I ~ ( C 1 1 C ~ - (19.37). II7)CO; etc. T h e configurations of the amino acid residues zrppear i i i ( 7 ) The coinpounds arc numbered t o corresImnd with the numberinn parentheses after t h e name of the compound. i n Tab!e I . ( 5 ) For a discussion of diastereoisomer formation, see H . U. Springall (8) B. 1'. Erlanger and I